| 2011 |
NEK4 serine/threonine kinase was identified as a prominent component of both the RPGRIP1- and RPGRIP1L-associated protein complexes by tandem affinity purification/mass spectrometry. In ciliated cells, NEK4 localizes to basal bodies, and in ciliated organs it is detected at the ciliary rootlet. Knockdown of NEK4 in ciliated cells caused a significant decrease in cilium assembly, establishing a role for NEK4 in cilium dynamics. |
Tandem affinity purification + mass spectrometry (complex identification); immunolocalization in ciliated cells/organs; siRNA knockdown with cilium assembly readout |
Human molecular genetics |
Medium |
21685204
|
| 2012 |
NEK4 suppression extended replicative lifespan in human fibroblasts and reduced p21 transcription. NEK4 forms a complex with DNA-PKcs, Ku70, and Ku80 (identified by MS of immune complexes). NEK4 suppression impaired DNA-PKcs recruitment to double-strand breaks, resulting in reduced p53 activation and H2AX phosphorylation, thereby implicating NEK4 in the DNA damage response pathway. |
RNAi loss-of-function screen; mass spectrometric analysis of Nek4 immune complexes; co-immunoprecipitation; cell cycle and senescence assays; γH2AX and p53 phosphorylation assays after DSB induction |
Molecular and cellular biology |
High |
22851694
|
| 2010 |
NEK4 promotes microtubule outgrowth after Taxol treatment and is required for G2/M arrest and mitotic aster formation. Nek4 deficiency impaired G2/M arrest in response to the microtubule-stabilizing drug Taxol but sensitized cells to the microtubule-destabilizing drug vincristine, establishing a role for NEK4 in microtubule dynamics and differential response to microtubule poisons. |
Genetic screen (RNAi/loss-of-function); microtubule outgrowth assays; cell cycle analysis (G2/M arrest); mitotic aster formation assays after drug treatment |
Cancer research |
Medium |
20103636
|
| 2015 |
Immunoprecipitation-mass spectrometry of two NEK4 isoforms identified 474 interacting proteins for isoform 1 and 149 for isoform 2, with ~68% overlap. Key interactors include DNA-PKcs complex members (consistent with DNA damage role), PCNA, 14-3-3ε, splicing factors SRSF1, SRSF2, SRPK1, and hnRNP proteins. Isoform 1 (but not isoform 2) participates in RNA splicing control, and the two isoforms showed opposite effects in some processes, indicating isoform-specific functional differences. |
Immunoprecipitation followed by mass spectrometry of two NEK4 isoforms expressed in human cells; functional assays distinguishing isoform effects on RNA splicing |
Proteome science |
Medium |
25798074
|
| 2018 |
NEK4 acts as a positive regulator of EMT in lung adenocarcinoma cells. NEK4 knockdown increased E-cadherin and ZO1 expression, decreased Zeb1 and Smad proteins, and inhibited cell migration/invasion. NEK4 overexpression decreased E-cadherin and increased Smad3 expression. In vivo tail-vein injection of NEK4-knockdown cells showed reduced tumor formation and metastasis, placing NEK4 upstream of Zeb1 and Smad signaling in EMT. |
siRNA library screen with E-cadherin promoter-luciferase reporter; siRNA knockdown and overexpression with Western blot; migration/invasion assays; in vivo tail-vein injection mouse model |
Journal of cellular and molecular medicine |
Medium |
30247800
|
| 2022 |
NEK4 overexpression activates mitochondrial respiration coupled to ATP production, increases mitochondrial membrane potential, and confers resistance to mitochondrial DNA damage. NEK4 depletion reduced mitochondrial respiration and mtDNA integrity. NEK4 regulates mitochondrial morphology through the fission protein DRP1: NEK4 overexpression increased DRP1 phosphorylation and Erk1/2 phosphorylation and promoted mitochondrial fission, while NEK4 deficiency caused mitochondrial elongation. The mitochondrial respiration effect of NEK4 overexpression was abolished by a DRP1 inhibitor. |
NEK4 overexpression and siRNA depletion; mitochondrial respiration assays (Seahorse); mitochondrial membrane potential assays; mtDNA damage assays; DRP1 and Erk1/2 phosphorylation by Western blot; DRP1 inhibitor epistasis |
The FEBS journal |
Medium |
34986513
|
| 2021 |
Novel quinazolinamine analogues derived from Spautin-1 were identified as potent NEK4 inhibitors with IC50 ~1 µM, demonstrating that NEK4 kinase activity can be pharmacologically inhibited and that its inhibition is at least partially responsible for anti-proliferative activity in EGFR-mutant NSCLC cells. |
Structure-activity relationship study; kinase inhibition assays (IC50 determination); anti-proliferative cell assays |
International journal of molecular sciences |
Low |
33435251
|
| 2024 |
NEK4 overexpression in pyramidal neurons (transgenic mice or AAV) caused circadian shifts in anxiety behavior and affected diurnal fluctuations in dendritic spine morphology and synaptic structure. Phosphoproteomic analyses revealed that NEK4 overexpression alters diurnal and nocturnal phosphoproteomic profiles. Lithium treatment ameliorated the behavioral effects of NEK4 overexpression. |
Conditional transgenic NEK4 overexpression in forebrain pyramidal neurons; AAV-mediated hippocampal overexpression; behavioral assays (anxiety); confocal imaging of dendritic spines; phosphoproteomic analysis; lithium treatment |
Nature communications |
Medium |
39448584
|
| 2025 |
NEK4 depletion in triple-negative breast cancer (BT20) cells upregulated cell cycle and mitosis genes and downregulated mRNA splicing genes (by RNA-seq), shifted cell cycle distribution toward G2/M, and stimulated proliferation — opposite to effects in other cell lines. NEK4 depletion decreased γH2AX foci after etoposide treatment but did not affect basal DNA damage levels, confirming a role in DNA damage response. NEK4 depletion did not consistently alter p21 expression across cell lines. |
NEK4 siRNA depletion; live-cell imaging of proliferation; RNA-seq with enrichment analysis; cell cycle distribution by flow cytometry; γH2AX foci after etoposide |
Frontiers in oncology |
Medium |
41001016
|
| 2026 |
TXNDC15 interacts with NEK4 and suppresses lung adenocarcinoma cell proliferation by inducing G2/M phase arrest, placing NEK4 downstream of TXNDC15 in G2/M checkpoint regulation. |
Co-immunoprecipitation (TXNDC15-NEK4 interaction); functional assays (proliferation, cell cycle distribution); G2/M checkpoint readouts |
Biochemical and biophysical research communications |
Low |
42214920
|